SCHEMBL28848819

SCHEMBL28848819

CC(C)(C)OC(=O)Nc1cc(-n2cnc3c2CCCC3)ccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3C3 Q8NEB9 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ PDE3B Q13370 5/20 0.38
▸ PDE3A Q14432 5/20 0.38
▸ PDE2A O00408 2/20 0.37
▸ PDE1A P54750 1/20 0.37
▸ PDE1B Q01064 1/20 0.37
▸ PDE1C Q14123 1/20 0.37
▸ IGF1R P08069 1/20 0.37
▸ TGFBR1 P36897 1/20 0.36
▸ ATR Q13535 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.35
▸ RIPK3 Q9Y572 1/20 0.35
▸ P2RX3 P56373 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ AAK1 Q2M2I8 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ PDK2 Q15119 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25776011 0.74 PRKDC (0.47) PIK3C3GSK3BDYRK1A
SCHEMBL946000 0.72 PDE3B (0.43) PDE3BPDE3APDE2APDE1APDE1B
SCHEMBL23749755 0.72 IGF1R (0.40) PIK3C3GSK3BDYRK1AIGF1RTGFBR1
SCHEMBL28848830 0.71 PDE3B (0.43) PDE3BPDE3APDE2APDE1APDE1B
SCHEMBL28953804 0.71 PDE3B (0.40) PDE3BPDE3APDE2APDE1APDE1B
SCHEMBL1192656 0.70 ATR (0.50) GSK3BDYRK1AIGF1RTGFBR1ATR
SCHEMBL828560 0.70 TP53 (0.51) —
SCHEMBL30953487 0.70 ATR (0.50) GSK3BDYRK1AIGF1RTGFBR1ATR
SCHEMBL23727744 0.69 IGF1R (0.38) PIK3C3GSK3BDYRK1AIGF1RTGFBR1
SCHEMBL23727741 0.69 IGF1R (0.38) PIK3C3GSK3BDYRK1AIGF1RTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110036005-B Amide derivatives and their use in medicine 广东东阳光药业有限公司 2022-09-27 — — CN disclosed
Send feedback